Shree Ganesh Remedies Receives Upgraded Stock Call from MarketsMOJO

Shree Ganesh Remedies, a microcap pharmaceutical company, has recently received an upgraded stock call from MarketsMOJO. The company's stock has been upgraded to 'Hold' on April 23, 2024.
The decision to upgrade the stock is based on several factors. Firstly, the company has a low Debt to Equity ratio, which is a positive sign for investors. Additionally, Shree Ganesh Remedies has shown healthy long-term growth with its Net Sales increasing at an annual rate of 33.54%.

Moreover, the company has declared positive results for the last four consecutive quarters, with its profits growing at a significant rate. The PAT (HY) has grown by 36.91%, PBT LESS OI (Q) has grown by 44.39%, and NET SALES (Q) has grown by 27.19%.

From a technical standpoint, the stock is currently in a mildly bullish range and has shown a 1.62% return since April 22, 2024. The MACD and KST technical factors are also bullish, indicating a positive trend for the stock.

In terms of market performance, Shree Ganesh Remedies has outperformed the market (BSE 500) with a return of 100.21% in the last year. However, with a ROCE of 20.1, the stock is currently trading at a premium compared to its average historical valuations. The PEG ratio of the company is 0.7, which suggests that the stock may be slightly overvalued.

It is worth noting that despite its size, domestic mutual funds hold only 0% of the company. This could indicate that they are either not comfortable with the current price or have not conducted in-depth research on the company.

Overall, Shree Ganesh Remedies has shown promising growth and has received an upgraded stock call from MarketsMOJO. However, investors should carefully consider the company's valuation and do their own research before making any investment decisions.